Conference Report: WC11 2021
Conference Report: World Congress on Alternatives and Animal Use in the Life Sciences (WC11) 08/23 – 09/02/2021
From August 23 to September 2, 2021, the online conference WC11 took place under the motto “3Rs in Transition: From Development to Application”. The 3R principle includes the replacement, reduction, and refinement of animal experiments, which are used as standard for the testing of pharmaceutical ingredients, chemicals, or cosmetics.
The focus of the conference was on animal welfare, ethical issues, innovative technologies for the reduction of animal models and the translation of these replacement models. The greatest challenges for novel organ models were emphasized as reproducibility, automation, and standardization. In addition to the exciting lecture series, there was the opportunity to participate in numerous workshops on career development, scientific publishing, and networking.
Our PhD student Tim Kaden was nominated for the “YOU-WC11 3R Early Career Scientist Award” at the “Let the Stars Shine” workshop and presented his research results on drug-induced liver damage caused by paracetamol, trovafloxacin and levofloxacin in our liver model as a possible alternative to animal experiments.
Because Dynamic42 follows the philosophy of minimizing animal experiments with our human organ models and thereby avoiding animal suffering, the exciting presentations during the conference were trendsetting and showed the urgency to develop and improve our models.
Picture: Promotional Toolkit – WC11 Maastricht
More interesting articles:
Blog
Will organ-on-chip replace animal testing?
Will advanced in vitro models such as organ-on-chip replace animal testing? An opinion piece by our CEO and co-foudner Dr. Martin Raasch.
Read MoreBlog
What is TEER? – Trans-Epithelial Electrical Resistance Assay
Here we explore TEER assays as an excellent method to determine barrier, and thereby epithelial and endothelial tissue integrity.
Read MoreBlog
What is organ-on-chip?
This blog provides an introduction to organ-on-chip, a technology that can bridge the gap between 2D-cell-culture and animal experiments.
Read More